The Efficacy of Rupatadine fumarate on Pai
Phase 2
Suspended
- Conditions
- herpes zoster
- Registration Number
- JPRN-jRCTs021190010
- Lead Sponsor
- kono michihiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
1) age:20-years-old or older
2) patients with acute herpes zoster within 2 weeks
Exclusion Criteria
1) patients with severe liver, kidney, heart disease, or diabetes
2) patients receiving medications that affect pain
3) patients with hypersensitivity to rupatazine fumarate
4) pregnant and nursing patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method